Skip to main content Skip to footer

Press Releases

Bringing Science to Society™

Investors

Investors

  • Overview
  • Press Releases
  • Investor Events
  • Presentations
  • Governance
    • Governance Documents
    • Management Team
    • Board of Directors
    • Board Committees
  • Stock Information
    • Quote
    • Analyst Coverage
  • Financials & Filings
    • SEC Filings
Mar 20, 2023 7:00am EDT

Societal CDMO Announces U.S. FDA Approval for Manufacturing of Commercial Tablet at Gainesville, Georgia Site

Mar 03, 2023 7:00am EST

Societal CDMO to Participate at 35th Annual Roth Conference

Mar 01, 2023 4:05pm EST

Societal CDMO Reports Fourth Quarter and Full Year 2022 Financial Results

Feb 22, 2023 4:05pm EST

Societal CDMO to Report Financial Results for Fourth Quarter and Year-End 2022 on March 1, 2023

Feb 01, 2023 7:00am EST

Societal CDMO Highlights Growth of Existing Customer Business Through Signing of More Than $6 Million in Work Orders During Fourth Quarter of 2022

Jan 06, 2023 7:00am EST

Societal CDMO Reports Inducement Grants for New Staff

Dec 16, 2022 9:25am EST

Societal CDMO Completes Strategic Recast of Capital Structure Highlighted by Reduction and Refinancing of Outstanding Debt

Dec 14, 2022 4:05pm EST

Societal CDMO Announces Closing of $35.6 Million Concurrent Public Offerings

Dec 12, 2022 9:26am EST

Societal CDMO Announces Pricing of $35.6 Million Concurrent Public Offerings

Dec 12, 2022 6:45am EST

Societal CDMO Announces Proposed Concurrent Public Offerings of Common Stock and Preferred Stock

  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Page 24
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
Copyright ©2023 Societal CDMO. All rights reserved. Manage Cookie Preferences
Follow us